Following an investigation from the Ohio Attorney General’s office, state Planned Parenthood affiliates were cleared of selling fetal tissue, as previously alleged.
However, Ohio Attorney General Mike DeWine’s office has found state outlets of the national health organization are incorrectly disposing fetuses.
Through the Attorney General’s investigation of Planned Parenthood, officials found that aborted fetuses from Ohio affiliate offices are disposed of in landfills by third party waste management corporations.
“Disposing of aborted fetuses from an abortion by sending them to a landfill is callous and completely inhumane,” said Ohio Attorney General Mike DeWine in a press release. “It is important the public be aware that these practices are taking place at these Ohio facilities.”
Officials from area Planned Parenthood affiliates were not available for immediate comment.
Earlier this year, Ohio Attorney General Mike DeWine directed his Charitable Law Section to investigate whether Planned Parenthood offices in Bedford Heights, Cincinnati, and Columbus were violating Ohio law by selling fetal tissue, or abortion trafficking, in violation of Ohio Revised Code 2919.14.
The Charitable Law Section requested documents and financial records from Planned Parenthood organizations as well as companies they contracted with. The investigation did not find that fetal tissue was sold by Planned Parenthood affiliates in Ohio.
But the investigation showed that the disposal methods documented by the Planned Parenthood affiliates violate Ohio Administrative Code 3701-47-05, adopted in 1975, which requires that a “fetus shall be disposed of in a humane manner.”
According to DeWine’s office, “All three Ohio Planned Parenthood affiliates have sent fetal remains to companies which disposed of the fetuses in landfills. Additionally, the Planned Parenthood facility in Bedford Heights stated it uses only one company for disposal. However, that company stated to investigators it does not accept fetal remains for disposal as a corporate policy.”
DeWine referred his investigative findings to the Ohio Department of Health for further action.